Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.
T D Batiuk, … , L Kung, P F Halloran
T D Batiuk, … , L Kung, P F Halloran
Published October 1, 1997
Citation Information: J Clin Invest. 1997;100(7):1894-1901. https://doi.org/10.1172/JCI119719.
View: Text | PDF
Research Article Article has an altmetric score of 6

Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.

  • Text
  • PDF
Abstract

Research Article

Authors

T D Batiuk, L Kung, P F Halloran

×

Total citations by year

Year: 2021 2016 2015 2013 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1983 Total
Citations: 1 3 1 2 2 4 2 4 2 2 4 9 4 2 9 6 4 3 1 65
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (65)

Title and authors Publication Year
Sustained Inhibition of Calcineurin Activity With a Melt‐Dose Once‐daily Tacrolimus Formulation in Renal Transplant Recipients
P Fontova, H Colom, R RigoBonnin, O Bestard, A VidalAlabró, LN van Merendonk, G Cerezo, C Polo, N Montero, E Melilli, A Manonelles, M Meneghini, A Coloma, JM Cruzado, J Torras, JM Grinyó, N Lloberas
Clinical Pharmacology & Therapeutics 2021
Activation of the vitamin D receptor selectively interferes with calcineurin-mediated inflammation: a clinical evaluation in the abdominal aortic aneurysm
AJ Nieuwland, VB Kokje, OH Koning, JF Hamming, K Szuhai, FH Claas, JH Lindeman
Laboratory Investigation 2016
Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter
O Maguire, GL Chen, TE Hahn, L Brix, PL McCarthy, PK Wallace, H Minderman
Methods 2016
Pediatric Kidney Disease
DF Geary, F Schaefer
Pediatric Kidney Disease 2016
Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease
EG Quetglas
World journal of gastroenterology : WJG 2015
Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus
O Maguire, KM Tornatore, KL O'Loughlin, RC Venuto, H Minderman
Cytometry Part A 2013
Expression of Calcineurin Activity after Lung Transplantation: A 2-Year Follow-Up
S Sanquer, C Amrein, D Grenet, R Guillemain, B Philippe, V Boussaud, L Herry, C Lena, A Diouf, M Paunet, EM Billaud, F Loriaux, JP Jais, R Barouki, M Stern, A Gregson
PloS one 2013
Toward managing chronic rejection after lung transplant: The fate and effects of inhaled cyclosporine in a complex environment
RW Niven
Advanced Drug Delivery Reviews 2011
Pharmacodynamic Monitoring of Canine T-Cell Cytokine Responses to Oral Cyclosporine
TM Archer, CL Fellman, JV Stokes, LM Pinchuk, KV Lunsford, SB Pruett, VC Langston, AJ Mackin
Journal of Veterinary Internal Medicine 2011
Biomarkers
F Dieterle, FD Sistare
Biomarkers 2010
Effects of Ultraviolet A-1 Radiation on Calcineurin Activity and Cytokine Production in (Skin) Cell Cultures
N Smit, R Musson, F Romijn, H Rossum, J Pelt
Photochemistry and Photobiology 2010
Immunopotentiation on murine spleen lymphocytes induced by polysaccharide fraction ofPanax ginsengvia upregulating calcineurin activity
SD Zhang, YX Yin, Q Wei
APMIS 2010
Whole blood flow cytometric measurement of NFATc1 and IL-2 expression to analyze cyclosporine A-mediated effects in T cells
C Brandt, P Liman, H Bendfeldt, K Mueller, P Reinke, A Radbruch, M Worm, R Baumgrass
Cytometry Part A 2010
T-cell receptor-stimulated calcineurin activity is inhibited in isolated T cells from transplant patients
JA Tumlin, BR Roberts, KE Kokko, OE Minshawy, JL Gooch
The Journal of pharmacology and experimental therapeutics 2009
Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation
Y Tanaka, T Hasegawa, Z Chen, Y Okita, K Okada
The Journal of Thoracic and Cardiovascular Surgery 2009
Pharmacodynamic Monitoring of Calcineurin Phosphatase Activity in Transplant Patients Treated with Calcineurin Inhibitors
I YANO
Drug Metabolism and Pharmacokinetics 2008
Immunological Monitoring of Calcineurin Inhibitors for Predicting Cytomegalovirus Infection in Kidney Transplant Recipients
L Couzi, R Thiébaut, JC Carron, JF Moreau, P Merville, JL Taupin
Transplantation 2008
Comprehensive Pediatric Nephrology
R Gbadegesin, WE Smoyer
Comprehensive Pediatric Nephrology 2008
Variation in Leukocyte Subset Concentrations Affects Calcineurin Activity Measurement: Implications for Pharmacodynamic Monitoring Strategies
HH van Rossum, FP Romijn, KJ Sellar, NP Smit, PJ van der Boog, JW de Fijter, J van Pelt
Clinical chemistry 2008
Use of mTOR inhibitors in human organ transplantation
AS MacDonald
Expert Review of Clinical Immunology 2007
Increased Levels of NF-ATc2 Differentially Regulate CD154 and IL-2 Genes in T Cells from Patients with Systemic Lupus Erythematosus
VC Kyttaris, Y Wang, YT Juang, A Weinstein, GC Tsokos
Journal of immunology (Baltimore, Md. : 1950) 2007
Spectrophotometric assay for calcineurin activity in leukocytes isolated from human blood
KJ Sellar, HH van Rossum, FP Romijn, NP Smit, JW de Fijter, J Pelt
Analytical Biochemistry 2006
Suitable Whole Blood Levels 2 Hours After Neoral in Liver Transplant Patients: Experiences at a Single Center
KH Kim, SG Lee, YJ Lee, KM Park, S Hwang, CS Ahn, DB Moon, TY Ha, KW Song, DS Kim, DH Jung, BS Kim, KM Moon, HJ Lee, JI Park, JH Ryu
Transplantation Proceedings 2006
Localisation of High Acid Phosphotyrosine Phosphatase Activity in Afferent Arterioles and Glomeruli of Human Kidney
S Partanen
Journal Of Molecular Histology 2005
Cyclosporine Monitoring With 2-Hour Postdose Levels in Heart Transplant Recipients
SG Solari, LR Goldberg, D DeNofrio, LM Shaw
Therapeutic Drug Monitoring 2005
Inositol trisphosphate receptor calcium release is required for cerebral artery smooth muscle cell proliferation
MK Wilkerson
American journal of physiology. Heart and circulatory physiology 2005
Inhibition of the Calcineurin-NFAT Interaction by Small Organic Molecules Reflects Binding at an Allosteric Site
S Kang, H Li, A Rao, PG Hogan
The Journal of biological chemistry 2005
Barbiturates directly inhibit the calmodulin/calcineurin complex: a novel mechanism of inhibition of nuclear factor of activated T cells
M Humar, SE Pischke, T Loop, A Hoetzel, R Schmidt, C Klaas, HL Pahl, KK Geiger, BH Pannen
Molecular pharmacology 2004
DEFECTIVE INHIBITION OF PERIPHERAL CD8+ T CELL IL-2 PRODUCTION BY ANTI-CALCINEURIN DRUGS DURING ACUTE LIVER ALLOGRAFT REJECTION
E Boleslawski, F Conti, S Sanquer, P Podevin, S Chouzenoux, F Batteux, D Houssin, B Weill, Y Calmus
Transplantation 2004
Neoral C2 monitoring in maintenance liver transplant patients: A step forward?
GA Levy, EH Cole
Liver Transplantation 2004
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients
S Paolo, A Teutonico, G Stallone, B Infante, A Schena, G Grandaliano, M Battaglia, P Ditonno, PF Schena
Nephrology Dialysis Transplantation 2004
Neoral C2 monitoring in solid organ transplantation
GA Levy
Transplantation Proceedings 2004
Pharmacology of calcineurin antagonists
MH Kapturczak, HU Meier-Kriesche, B Kaplan
Transplantation Proceedings 2004
Calcineurin activity as a functional index of immunosuppression after allogeneic stem-cell transplantation1:
S Sanquer, M Schwarzinger, S Maury, K Yakouben, H Rafi, C Pautas, M Kuentz, R Barouki, C Cordonnier
Transplantation 2004
Distinct Inhibitory Effects of Tacrolimus and Cyclosporin A on Calcineurin Phosphatase Activity
M Fukudo, I Yano, S Masuda, M Okuda, K Inui
The Journal of pharmacology and experimental therapeutics 2004
Circulating levels of cyclosporin A in inflammatory bowel disease: relationships with lymphocyte inhibition and the age of patients
G Angeloni, M Latteri, R Manna, C Rumi, G Gasbarrini, P Navarra
European Journal of Clinical Pharmacology 2004
Failure of cyclosporin A to induce transforming growth factor beta (TGF-beta) synthesis in activated peripheral blood lymphocytes
M Goppelt-Struebe, B Esslinger, U Kunzendorf
Clinical Transplantation 2003
Atypical mechanisms regulate the PMA-induced expression of IFN-γ in a porcine trophectoderm cell line
P Marcelo, M Bernoin, F Lefèvre
Veterinary Immunology and Immunopathology 2003
Cyclosporine lymphocyte level and lymphocyte count: new guidelines for tailoring immunosuppressive therapy
A Barbari, A Stephan, M Masri, N Mourad, G Kamel, H Kilani, A Karam, IA Daya
Transplantation Proceedings 2003
Substitution in Position 3 of Cyclosporin A Abolishes the Cyclophilin-mediated Gain-of-function Mechanism but Not Immunosuppression
R Baumgrass, Y Zhang, F Erdmann, A Thiel, M Weiwad, A Radbruch, G Fischer
The Journal of biological chemistry 2003
New developments in immunosuppressive therapy in renal transplantation
S Gourishankar, P Turner, P Halloran
Expert Opinion on Biological Therapy 2002
Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts
MD Pescovitz, R Barbeito
Clinical Transplantation 2002
Tissue Distribution of Calcineurin and its Sensitivity to Inhibition by Cyclosporine
L Kung, TD Batiuk, S Palomo-Pinon, J Noujaim, LM Helms, PF Halloran
American Journal of Transplantation 2001
Controlling duration of contact between T cells and antigen-presenting cells
S Kim, NS Braunstein, EF Leonard, JL Thomas
Journal of Immunological Methods 2001
Functional quantification of cyclosporine A and FK506 in human whole blood by flow cytometry, using the green fluorescent protein as an interleukin-2 reporter gene
JL Taupin, P Merville, T McBride, L Potaux, JF Moreau
Journal of Immunological Methods 2001
Mechanism of action of the calcineurin inhibitors
PF Halloran
Transplantation Proceedings 2001
A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol
SM Moe, M Zekonis, J Harezlak, WT Ambrosius, CM Gassensmith, CL Murphy, RR Russell, TD Batiuk
American Journal of Kidney Diseases 2001
Cyclosporin: An Updated Review of the Pharmacokinetic Properties, Clinical Efficacy and Tolerability of a Microemulsion-Based Formulation (Neoral??)* in Organ Transplantation
CJ Dunn, AJ Wagstaff, CM Perry, GL Plosker, KL Goa
Drugs 2001
Modern Immunosuppressives
HJ Schuurman, G Feutren, JF Bach
2001
Role of T Cells and Gamma Interferon during Induction of Hypersensitivity to Lipopolysaccharide by Toxic Shock Syndrome Toxin 1 in Mice
JD Clements, MM Dinges, PM Schlievert
Infection and immunity 2001
Whole-Blood Calcineurin Activity Is Not Predicted by Cyclosporine Blood Concentration in Renal Transplant Recipients
R Caruso, N Perico, D Cattaneo, G Piccinini, S Bonazzola, G Remuzzi, F Gaspari
Clinical chemistry 2001
Molecular pharmacology of immunosuppressive agents in relation to their clinical use
L Kung, S Gourishankar, PF Halloran
Current Opinion in Organ Transplantation 2000
NEWCASTLE DISEASE ANTIBODY TITRE IS DEPENDENT ON SERUM CALCIUM CONCENTRATION
J Božičković, G Krivec, WL Ragland, H Mazija, P Božičković, E Prukner-Radovčić
Acta Veterinaria Hungarica 2000
Inhibition of calcineurin activity and protection against cyclosporine A induced cytotoxicity by prednisolone sodium succinate in human peripheral mononuclear cells
S Sipka, K Szücs, S Szántó, I Kovács, G Lakos, P Antal-Szalmás, G Szegedi, P Gergely
Immunopharmacology 2000
In vitro effect of retinoids on calcineurin activity
DJ Spannaus-Martin, BL Martin
Biochemical Pharmacology 2000
IMMUNOPHILINS MAY LIMIT CALCINEURIN INHIBITION BY CYCLOSPORINE AND TACROLIMUS AT HIGH DRUG CONCENTRATIONS1:
L Kung, PF Halloran
Transplantation 2000
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
BL Kasiske, MA Vazquez, WE Harmon, RS Brown, GM DANOVITCH, RS Gaston, DA Roth, JD Scandling, GG Singer
Journal of the American Society of Nephrology : JASN 2000
Ex VivoAssessment of Immunosuppression in Undiluted Whole Blood from Pigs Dosed with Tacrolimus (FK506)
YW Chen, ML Smith, MP Sheets, SJ Ballaron, JM Trevillyan, TA Fey, DM Gauvin, R Kolano, MS Pong, GC Hsieh, J Bauch, K Marsh, G Carter, J Luly, S Djuric, KW Mollison
Clinical Immunology 1999
Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin
B Ding, RL Price, TK Borg, EO Weinberg, PF Halloran, BH Lorell
Circulation research 1999
HUMAN T CELL RESPONSES TO HUMAN AND PORCINE ENDOTHELIAL CELLS ARE HIGHLY SENSITIVE TO CYCLOSPORIN A AND FK506 IN VITRO1:
P Batten, AM McCormack, CS Page, MH Yacoub, ML Rose
Transplantation 1999
THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1:
PF Halloran, LM Helms, L Kung, J Noujaim
Transplantation 1999
The Effect of Calcium-Related Factors on the Predominance of IFN-γ or Interleukin-4 in Cultured Mononuclear Cells
H Enomoto, S Yousefi, N Vaziri, S Khonsari, J Ocariz, MG Delayarian, T Cesario
Journal of Interferon & Cytokine Research 1998
New immunosuppressive strategies
PA Keown
Current Opinion in Nephrology and Hypertension 1998
Calcineurin and the biological effect of cyclosporine and tacrolimus
PF Halloran, L Kung, J Noujaim
Transplantation Proceedings 1998
New Comprehensive Biochemistry
S Yamamoto
New Comprehensive Biochemistry 1983

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
Referenced in 1 clinical guideline sources
9 readers on Mendeley
See more details